Dyskeratosis Congenita Autosomal Dominant 4 C3808802
An autosomal dominant form of dyskeratosis congenita with similar features to other types. It causes skin, nail, and mucosal changes with increased cancer risk. Lifelong monitoring and supportive care are essential.
Key facts at a glance
- ICD-10
- Q84.9
- ICD-11
- LA00.0
- Body system
- dermatologic
- Severity
- severe
- Chronic
- true
Signs and symptoms
Common signs and symptoms that may indicate this condition.
Generalized symptoms
(dermatologic)Significant symptoms that substantially affect daily functioning.
Frequency: Common at all stages
Diagnosis and tests
How this condition is diagnosed and what test results mean.
Initial screening tests
Standard diagnostic workup
Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]
Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]
Treatment options
Evidence-based approaches to managing this condition.
First-line treatments
Hematopoietic stem cell transplantation
Definitive treatment for bone marrow failure through replacement of affected hematopoietic cells with healthy donor stem cells, addressing the fundamental telomere biology defect in this autosomal dominant form.
Medication management with follow-up
Active treatment with regular monitoring by a healthcare provider is recommended.
Danazol for cytopenias
Synthetic androgen therapy to stimulate hematopoietic stem cell activity and improve peripheral blood counts in bone marrow failure when transplantation is not immediately feasible.
Additional treatment options
Pulmonary function monitoring
Serial pulmonary function testing and imaging to detect interstitial lung disease and pulmonary fibrosis, major causes of morbidity in dyskeratosis congenita type AD4.
monitoringInfection prevention protocols
Implementation of hygiene measures, prompt fever evaluation, prophylactic antibiotics when indicated, and avoidance strategies to minimize infection risk from immunocompromised state.
lifestyleStress management and wellness support
Integrative approaches including meditation, gentle exercise, and stress reduction techniques to support overall wellbeing and potentially modulate inflammatory pathways.
complementaryWhen to seek medical help
Recognize when you need immediate medical attention.
See a doctor within 24 hours
Moderate to severe symptoms that may indicate worsening of this condition. Prompt medical evaluation is recommended.
Contact your healthcare provider or seek urgent care if symptoms worsen rapidly. Go to the emergency department for life-threatening symptoms.
Frequently asked questions
Common questions about this topic.
What is Dyskeratosis Congenita Autosomal Dominant 4 C3808802?
Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]
generalMedication Comparisons
Compare medications used to treat Dyskeratosis Congenita Autosomal Dominant 4 C3808802. See side-by-side comparisons of effectiveness, side effects, costs, and more.
View Medication ComparisonsThis information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.
This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.
If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.
Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy